Clinical Trials Browser

Completed × Interventional × Rifaximin × Clear all

NCT01345175 2024-05-14

Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer

Phase 3 Completed

69 enrolled 9 charts

Gastrointestinal

Rectal Neoplasms

NCT00967096 2013-11-27

Rifaximin for Preventing Acute Graft Versus Host Disease (AGVHD)

Phase 1 Completed

Neoplasms